Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$SGTM Sustainable Green Team Secures Groundbreaking $20M Middle East Deal https://www.stocktitan.net/news/SGTM/sustainable-green-team-secures-groundbreaking-20m-middle-east-ui3d3pi8rho6.html
$ASPI ASP Isotopes Inc. (Nasdaq: ASPI) is a nanocap which means there is a higher potential for growth.
$ASPI ASP Isotopes Inc. (Nasdaq: ASPI) is a nanocap which means there is a higher potential for growth.
$ASPI Higher Potential For Growth:
In general, nano-cap companies have market capitalizations of less than $50 million.(7) Because nano-cap stocks are significantly smaller than mid cap or large cap companies, they have a higher potential to change valuation quickly.(8) As of 7/7/2023, ASP Isotopes Inc. (Nasdaq: ASPI) has a market cap of less than $25 million with a limited float size of 12.51 million shares according to MarketWatch.com
$EVKRF Strong Company Assets:
Grid Battery Metals Inc. (OTCQB: EVKRF) (TSXV: CELL) owns six million shares of Surge Battery Metals Inc (OTC: NILIF) (TSXV:NILI). The management team at Grid Battery Metals was also the founding management team of Surge Battery Metals and is very experienced in Nevada Lithium exploration for over a decade. As of July 2023, these marketable shares are worth another $3 million Canadian dollars ($2.260 U.S. dollars). Surge Battery Metals has a significant lithium discovery in Northern Nevada, originally located through the hard work of its founding management and geological teams in Nevada.
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$CBGL and $MMMW building partnerships and great technologies.
$KRTL ~ KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL ~ KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp.
$KRTL Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$KRTL ~ KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$PLPL The valuation, completed in Q1, 2023, highlights several key estimations that demonstrate the robustness of ByoPlanet's operations, ByoPlanet's enterprise value, and potential for long-term success.
https://seekingalpha.com/pr/19352540-third-party-valuation-firm-provides-estimated-valuation-of-byoplanets-subsidiary-of-plandai
$CBGL Cannabis Global and KRTL International Corp. Announce Exclusive Distribution Agreement for
https://www.globenewswire.com/news-release/2023/05/02/2659356/0/en/Cannabis-Global-and-KRTL-International-Corp-Announce-Exclusive-Distribution-Agreement-for-Huella-Singani.html
$CBGL Check out the talented management team: https://cannabisglobalinc.com/management/
$CBGL is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.
$CBGL is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.
$CBGL Some of our projects involve: hemp cultivation of up to 100 acres, unique powdered cannabis drinks product line and intellectual properties including patents and trademarks.
$CBGL is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.
$EMED During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.
$SGTM Orlando, FL, April 18, 2023 (GLOBE NEWSWIRE) -- The Sustainable Green Team, LTD. (OTCQX: SGTM) (“SGTM” or the “Company”), a provider of environmentally conscious solutions in the arbor care, disposal, and recycling industries reports audited fiscal 2022 year end results (fiscal year ended December 31, 2022) and announces its first Annual Shareholder Meeting, to be held May 12, 2023, 9:00am Eastern Time.
https://www.marketwatch.com/press-release/the-sustainable-green-team-ltd-reports-355m-in-revenue-and-1203m-in-assets-for-its-fiscal-2022-audited-ye-and-announces-its-first-annual-shareholder-meeting-2023-04-18?mod=mw_quote_news_seemore
$EMED Electricity enables information to circulate in the body, electrotherapy manipulates a specific part of the information by pulsating electrical waves interfering with the transmission of pain signals.
Our nervous system is composed of our brain and our spinal cord, which combine to form the central nervous system; and our sensory and motor nerves, which form the peripheral nervous system. Nerves send information about what is happening in our environment to the brain via the spinal cord. The brain then sends information back to our nerves, helping us to perform actions in response. By treating specific body areas and varying frequency, wavelength and intensity applied, electrotherapy devices can manipulate impulses and target actions to alleviate pain or they can disrupt pain signals.
$EMED Electromedical’s commitment to create long-lasting drug-free solutions to pain management is honored by the development of The WellnessPro Plus®, a technologically advanced TENS (transcutaneous electrical nerve stimulation) therapy device focusing on pain relief.
$EMED As the Company moves closer to production of the new next-generation flagship device, management plans to offer a special upgrade and exchange program to existing clients, which will be bundled with a lifetime warranty.
$SGTM Launching into 2023 with Vision & Strategy
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.
$EMED During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.
$SGTM’s Net Revenue for the 2022 fiscal year end was $35,513,231, an increase of 11.24% in Net Revenue from $31,925,731 for the 2021 fiscal year end.
SGTM’s Gross Profit for the 2022 fiscal year end was $8,000,152, an increase of 505.54% in Gross Profit from $1,321,166 for the 2021 fiscal year end.
SGTM’s Net Income from operations for the 2022 fiscal year end was $8,901,214, an increase of 70.28% in Net Income from $5,227,362 for the 2021 fiscal year end.
SGTM’s Assets for the 2022 fiscal year end were $120,365,084, an increase of 80.17% in Assets from $66,805,152 for the 2021 fiscal year end.
SGTM’s Outstanding Shares for the 2022 fiscal year end was 74,631,743, a decrease of 17.5% from the Outstanding Shares of 90,460,425 for the 2021 fiscal year end.
https://seekingalpha.com/pr/19295506-sustainable-green-team-ltd-reports-35_5m-in-revenue-and-120_3m-in-assets-for-fiscal-2022
$EMED Electromedical Technologies Announces Preliminary Unaudited Revenue for Q4 and FY 2022 and update on operations
https://finance.yahoo.com/news/electromedical-technologies-announces-preliminary-unaudited-121900011.html
$EMED Despite the benefits of a diverse consumer drug market for pain managment, the non-medical use of pharmaceutical opioids has triggered new health threats & an escalating drug abuse epidemic.
$EMED Despite the benefits of a diverse consumer drug market for pain managment, the non-medical use of pharmaceutical opioids has triggered new health threats & an escalating drug abuse epidemic.
$EMED Management notes that 2023 will see the launch of the WellnessPro Infinity™, continued expansion in its sales team, a strong focus on value-add strategic partnerships, research partnerships and further customer affordability strategies as the Company monetizes its market-leading next-generation drug-free pain therapy technology.
$EMED Management notes that 2023 will see the launch of the WellnessPro Infinity™, continued expansion in its sales team, a strong focus on value-add strategic partnerships, research partnerships and further customer affordability strategies as the Company monetizes its market-leading next-generation drug-free pain therapy technology.
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED As the Company moves closer to production of the new next-generation flagship device, management plans to offer a special upgrade and exchange program to existing clients, which will be bundled with a lifetime warranty.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Our mission
Over 80 million Americans live with moderate to severe pain resulting from an accident or a disease, nearly 40% of them report being unable to find adequate pain relief and 77% report feeling depressed due to their chronic pain.
Our goal is to unlock the body’s natural ability to achieve wellness through high performance electrotherapy technologies, using energy, frequency and vibrations to improve quality of life.
Activists of a drug free approach, we take prescription drug misuse very seriously.
Alarming statistics have highlighted the importance of an alternative method for pain management.
https://electromedtech.com/our-mission/
$EMED Electromedical’s commitment to create long-lasting drug-free solutions to pain management is honored by the development of The WellnessPro Plus®, a technologically advanced TENS (transcutaneous electrical nerve stimulation) therapy device focusing on pain relief.
$CLNV April 11, 2023 / Clean Vision Corporation (OTCQB:CLNV) ("Clean Vision" or the "Company"), an emerging leader in the sustainable clean technology and green energy sectors, is excited to announce that its wholly owned subsidiary, Clean-Seas, Inc. ("Clean-Seas"), has entered into feedstock and site lease agreements (the "Agreements") pursuant to its previously announced $20 million joint venture project in Western Michigan in partnership with the NuWay Go Recycle Center LLC ("NWG") owned by American Classic (www.americanclassic.us), creating Clean-Seas Newaygo ("CSN").
$EMED Our mission
Over 80 million Americans live with moderate to severe pain resulting from an accident or a disease, nearly 40% of them report being unable to find adequate pain relief and 77% report feeling depressed due to their chronic pain.
Our goal is to unlock the body’s natural ability to achieve wellness through high performance electrotherapy technologies, using energy, frequency and vibrations to improve quality of life.
Activists of a drug free approach, we take prescription drug misuse very seriously.
Alarming statistics have highlighted the importance of an alternative method for pain management.
https://electromedtech.com/our-mission/
$EMED Management notes that 2023 will see the launch of the WellnessPro Infinity™, continued expansion in its sales team, a strong focus on value-add strategic partnerships, research partnerships and further customer affordability strategies as the Company monetizes its market-leading next-generation drug-free pain therapy technology.
$EMED Overview https://www.otcmarkets.com/stock/EMED/overview